Last mentioned: Mar 13, 2026
The Environmental Protection Agency (EPA) has moved to ease pollution restrictions on ethylene oxide (EtO), a critical chemical used to sterilize half of all U.S. medical devices. This regulatory shift aims to prevent potential healthcare supply chain disruptions but faces immediate backlash from environmental and public health advocates.
The global minimally invasive surgical devices market is projected to grow at a 7% CAGR through 2034, driven by technological advancements and a shift toward outpatient care. This growth reflects a broader healthcare transition prioritizing reduced recovery times and improved patient outcomes.
A new DelveInsight report projects a steady 7% CAGR for the minimally invasive surgical devices (MISD) market through 2034, driven by technological leaps in robotics and a global shift toward outpatient care. This expansion reflects a broader healthcare transition prioritizing reduced recovery times and improved clinical outcomes over traditional open surgeries.
The Australian government is significantly reducing subsidies for high-cost spinal cord stimulators following reports of severe patient injuries and a lack of clinical efficacy. This regulatory shift targets a multi-million dollar sector of the medical device market, forcing manufacturers to justify the high price tags of chronic pain technologies.
Globus Medical (GMED) reported a year-over-year advance in fourth-quarter profit, underscoring the successful integration of its $3.1 billion NuVasive acquisition. The results highlight the company's growing dominance in the spine robotics and musculoskeletal markets.
Wall Street Zen has upgraded Medtronic, Reliance, and Element Solutions to 'Buy' ratings, signaling a bullish outlook across healthcare and industrial sectors. These upgrades reflect a strategic pivot toward high-quality dividend payers and market leaders as industrial demand stabilizes.
US equities faced a volatile session as investors reassessed the 'dark side' of AI disruption, dragging the Nasdaq into its fifth consecutive week of losses. Within the healthcare sector, attention is fixed on Medtronic's earnings and Masimo's performance as the industry grapples with shifting valuations.